Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-23-006880

EVP, Global Sales & Marketing sold 29,133 shares at an average $5.72 ($166,517)

  • EVP, Global Sales & Marketing acquired 29,133 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ross Thomas M. EVP, Global Sales & Marketing 2023-02-01 Option exercise +2,468 $0.98 $2,426 2,468 D
Ross Thomas M. EVP, Global Sales & Marketing 2023-02-01 Option exercise +15,090 $2.14 $32,323 17,558 D
Ross Thomas M. EVP, Global Sales & Marketing 2023-02-01 Sale −17,558 $5.68 $99,729 0 D
Ross Thomas M. EVP, Global Sales & Marketing 2023-02-02 Option exercise +11,575 $2.14 $24,794 11,575 D
Ross Thomas M. EVP, Global Sales & Marketing 2023-02-02 Sale −11,575 $5.77 $66,788 0 D
Derivatives
Ross Thomas M. EVP, Global Sales & Marketing 2023-02-01 Option exercise · Employee Stock Option (right to buy) −2,468 0 D
Ross Thomas M. EVP, Global Sales & Marketing 2023-02-01 Option exercise · Employee Stock Option (right to buy) −15,090 83,710 D
Ross Thomas M. EVP, Global Sales & Marketing 2023-02-02 Option exercise · Employee Stock Option (right to buy) −11,575 72,135 D
Open-market sales · 29,133 sh · avg $5.72 · $166,517
Loading xslF345X03/doc4.xml…